Potential risks of cell-free concentrated ascites reinfusion therapy in TAFRO syndrome patient

MeSH terms

• Ascites* / etiology
• Ascites* / therapy
• Castleman Disease / complications
• Castleman Disease / therapy
• Cell-Free System
• Female
• Humans
• Male
• Middle Aged
• Primary Myelofibrosis / complications
• Primary Myelofibrosis / therapy